Bio-Techne (TECH) Other Non-Current Assets (2010 - 2026)

Bio-Techne's (TECH) quarterly Other Non-Current Assets came in at $264.4 million in Q1 2026, down 1.72% year-on-year from $269.0 million in Q1 2025, and down 1.02% quarter-over-quarter from $267.1 million in Q4 2025.

Bio-Techne (TECH) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Bio-Techne's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $264.4 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 1.72% year-over-year to $264.4 million in Q1 2026; TTM through Mar 2026 was $264.4 million, a 1.72% decrease from a year earlier, with the FY2025 full-year figure at $12.3 million, down 95.33% from the prior year.
  • Other Non-Current Assets retreated to $264.4 million in Q1 2026 per TECH's latest filing, from $267.1 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $285.3 million in Q2 2023 and bottomed at $1.0 million in Q4 2024.
  • The 5-year median for Other Non-Current Assets is $53.9 million (2022), against an average of $145.1 million.
  • Across the five-year window, Other Non-Current Assets sank 96.64% in 2024 and soared 25409.46% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $53.2 million in 2022, then sank by 49.91% to $26.6 million in 2023, then slumped by 96.07% to $1.0 million in 2024, then surged by 25409.46% to $267.1 million in 2025, then slipped by 1.02% to $264.4 million in 2026.
  • Per Business Quant, the three latest TECH Other Non-Current Assets figures stand at $264.4 million (Q1 2026), $267.1 million (Q4 2025), and $276.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn 264.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 264.37 Mn
Dec 31, 2025 267.08 Mn
Sep 30, 2025 276.56 Mn
Jun 30, 2025 12.33 Mn
Mar 31, 2025 268.99 Mn
Dec 31, 2024 1.05 Mn
Sep 30, 2024 9.46 Mn
Jun 30, 2024 264.27 Mn
Mar 31, 2024 26.67 Mn
Dec 31, 2023 26.65 Mn
Sep 30, 2023 281.58 Mn
Jun 30, 2023 285.30 Mn
Mar 31, 2023 283.35 Mn
Dec 31, 2022 53.19 Mn
Sep 30, 2022 53.90 Mn
Jun 30, 2022 46.83 Mn
Mar 31, 2022 45.98 Mn
Dec 31, 2021 37.11 Mn
Sep 30, 2021 11.59 Mn
Jun 30, 2021 11.58 Mn